Definitive Contract HHSN261201100032C

Ended Awarded Last action

Contract number
HHSN261201100032C
Awardee
Awarding agency
Obligated
$2,959,055

Award facts

Opportunity
  • HHSN261201100032C Solicitation number
Contract value 36% obligated
  • $2,959,055.20 Current, with exercised options
  • $8,145,946.20 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 12 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Canada

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out 21 · Purpose of this modification is to DE-obligate the remaining funds and close the contract -$744,884
Other Administrative Action 19 $0
Other Administrative Action 20 · Early therapeutics development with phase II emphasis -$56,403
Change Order 18 -$241,229
Other Administrative Action 17 · Other function - early therapeutics development with phase II emphasis $0
Exercise an Option 16 · Early therapeutics development with phase II emphasis $450,546
Exercise an Option 15 · Other function - early therapeutics development with phase II emphasis $170,159
Exercise an Option 14 · Early therapeutics development with phase II emphasis $191,435
Exercise an Option 13 $255,244
Exercise an Option 12 $49,037
Exercise an Option 11 $518,461
Exercise an Option 10 · Other function - early therapeutics development with phase II emphasis $62,302
Exercise an Option 9 · Early therapeutics development with phase II emphasis $166,236
Exercise an Option 8 $38,938
Exercise an Option 7 $12,472
Other Administrative Action 6 $0
Exercise an Option 5 $492,179
Exercise an Option 4 $29,160
Exercise an Option 3 $4,860
Other Administrative Action 2 · Other functions option YR 1 extended services. 09/23/2012 - 09/22/2013. Early therapeutics development with phase II emphasis. HHSN261201100032C. 8428006. $0
Exercise an Option 1 · Option YR 1 extended services. 09/23/2012 - 09/22/2013. Early therapeutics development with phase II emphasis. HHSN261201100032C. 8428006. $760,425
Original award $800,117
Show all 22

Quick answers

Who was awarded contract HHSN261201100032C?

HHSN261201100032C was awarded to University Health Network by National Cancer Institute (National Institutes of Health) on September 23, 2011.

How much is contract HHSN261201100032C worth?

The government has obligated $2,959,055 on HHSN261201100032C. Its potential value, with all options, is $8,145,946.

Was contract HHSN261201100032C competed?

The extent of competition for HHSN261201100032C was full and open competition. The government received 12 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login